Integrum AB (6Y1)

Overview

Integrum AB (publ) is a pioneering entity in the field of bone-anchored prostheses, dedicated to the research, development, and commercialization of advanced systems designed to provide amputees with high-quality life enhancements. Since its inception in 1962, the company has been at the forefront of introducing innovative solutions that enable direct attachment of prostheses to the bone, thus eliminating the need for traditional sockets. Headquartered in Mölndal, Sweden, Integrum serves a global client base comprising hospitals, clinics, and orthopedists, offering them cutting-edge prosthetic technologies that promise improved patient outcomes and comfort.

Products and Services

• Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) Implant Systems:

  The OPRA implant system signifies a groundbreaking approach in the field of prosthetic attachment, utilizing the principle of osseointegration. This methodology ensures that prosthetic limbs are anchored directly to the patient's bone, thus providing a more natural and comfortable experience compared to conventional socket-based prostheses. One of its notable benefits includes enhanced protection for the user against bone fractures, which could arise from accidental loads. This innovative system underscores Integrum’s commitment to delivering solutions that significantly improve the quality of life for amputees.

• Neuromotus:

  This sophisticated technology represents a considerable advancement in the treatment of phantom limb pain, a common ailment experienced by amputees. Neuromotus is designed to utilize the principles of neuromodulation through therapeutic methods, effectively reducing or eliminating the pain associated with the loss of a limb. By incorporating Neuromotus into their rehabilitation process, patients can experience significant relief from phantom limb pain, further illustrating Integrum’s dedication to addressing the comprehensive needs of amputees.